Jose O. Hernandez

FDA investigator

Appears on 12 documents from 2015 to 2020, mostly at sites in New York. Most often cites general requirements (21 CFR 211.160).

12
Documents on file
5.8
Observations per 483
2015
First seen
2020
Most recent

What they cite most

From 69 observations

Activity by year

2015: 1, 2016: 3, 2017: 1, 2018: 2, 2019: 4, 2020: 1

Where

New York 9 · China 2 · New Jersey 1

Is Jose O. Hernandez coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

12 documents, newest first
FirmOpen
483 Infusion Options, Inc.Jun 25, 2020 · Brooklyn, New York
483 Syntho Pharmaceuticals Inc.Sep 3, 2019 · Farmingdale, New York
483 Yaopharma Co., Ltd.Mar 29, 2019 · Chongqing, China
483 Yung Shin Pharm.Ind.(Kunshan) Co.,Ltd.Mar 15, 2019 · Suzhou, China
483 Tris Pharma IncJan 23, 2019 · Monmouth Junction, New Jersey
483 InvaGen Pharmaceuticals, Inc.Dec 19, 2018 · Central Islip, New York
483 Gemini Pharmaceuticals, Inc. dba Plus PharmaFeb 16, 2018 · Commack, New York

About this profile

What does Jose O. Hernandez inspect?

Jose O. Hernandez appears on 12 documents on file covering 11 sites, mostly in New York.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.42 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jose O. Hernandez is dated Jun 25, 2020.